Navigation Links
Alexza Pharmaceuticals Files Shelf Registration Statement
Date:5/4/2010

p>AZ-002 (Staccato alprazolam) has completed Phase 1 testing and one Phase 2a proof-of-concept clinical trial.  Product candidates that have completed Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, and AZ-007 (Staccato zaleplon) for the treatment of insomnia.  More information, including this and past press releases from Alexza, is available online at www.alexza.com.

Safe Harbor Statement

This news release contains forward-looking statements that involve significant risks and uncertainties.  Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs.  The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements.  These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K for the year ended December 31, 2009, and the Company's other Periodic and Current Reports filed with the Securities and Exchange Commission.  Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future eve
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... BARCELONA, Spain , July 4, 2015 /PRNewswire/ ... to first-line chemotherapy for patients with unresectable metastatic ... Progression-Free Survival in that organ Patients ... spread only to the liver experienced the greatest ... from the addition of SIR-Spheres Y-90 resin microspheres ...
(Date:7/3/2015)... Mexique, July 3, 2015 ... les épidémies que sont l,hypertension, le diabète et ... de plateformes éducatives gratuites et d,une conférence majeure ... http://photos.prnewswire.com/prnh/20150630/227033 ) , Les ... ligne , Prendre en charge l,hypertension en ...
(Date:7/3/2015)... , July 3, 2015 ... with Broda Technologies Co., Ltd., operating in both the ... the company,s proprietary IntelliGel ® supramolecular hydrogel technology ... development and other ophthalmic therapies. The Broda technology offers ... solution is a free-forming liquid and with low concentrations ...
Breaking Medicine Technology:New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2
... 2009 . , ... , , ... ... "2009 was a year of continued regulatory progress and scientific discovery," said Isaac ...
... KINGWOOD, Texas , March 15 ... www.imaiinc.com announced today that the company has completed ... company Organic Science, Inc. in an all stock ... of IMAI in this business segment, and is ...
Cached Medicine Technology:Bionovo Announces 2009 Highlights and Year-End Financial Results 2Bionovo Announces 2009 Highlights and Year-End Financial Results 3Bionovo Announces 2009 Highlights and Year-End Financial Results 4Bionovo Announces 2009 Highlights and Year-End Financial Results 5Bionovo Announces 2009 Highlights and Year-End Financial Results 6Bionovo Announces 2009 Highlights and Year-End Financial Results 7Bionovo Announces 2009 Highlights and Year-End Financial Results 8Bionovo Announces 2009 Highlights and Year-End Financial Results 9Bionovo Announces 2009 Highlights and Year-End Financial Results 10Bionovo Announces 2009 Highlights and Year-End Financial Results 11Bionovo Announces 2009 Highlights and Year-End Financial Results 12Bionovo Announces 2009 Highlights and Year-End Financial Results 13Bionovo Announces 2009 Highlights and Year-End Financial Results 14Bionovo Announces 2009 Highlights and Year-End Financial Results 15International Merchant Advisors Completes All Stock Based Purchase of Medical Marijuana Company Organic Science, Inc. 2International Merchant Advisors Completes All Stock Based Purchase of Medical Marijuana Company Organic Science, Inc. 3
(Date:7/3/2015)... ... , ... Talcum powder attorneys representing clients in national lawsuits announce the launch ... website. Just as the previous version did, the new website will serve as a ... ovarian cancer warning information. The site is routinely updated with news articles on talcum ...
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at ... that he says will reveal biblical truth and expose popular lies regarding proper relationships ... Say Don’t Have Sex”, immediately goes into the core of the subject by explaining ...
(Date:7/2/2015)... ... 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... Lone Star State. The premium frozen yogurt chain was listed as #22 on the Inc. ... in the Village at Bachman Lake, is located at:, 3701 W. Northwest Highway, STE 430, ...
(Date:7/2/2015)... ... 02, 2015 , ... When Walker Parking Consultants specified Kenall ... Minnesota, they knew it would save the university energy and maintenance costs. What ... total energy savings after installation was an impressive 89 percent, which resulted in ...
(Date:7/2/2015)... ... ... “ LIFX ” was featured on NewsWatch as part of its monthly ... Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and shared ... the market. , According to the U.S. Department of Energy, it’s very important to ...
Breaking Medicine News(10 mins):Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2
... ensure that the correct dose is administered to the 670,000 ... a new device developed by scientists at the National Physical ... has increased by 36% over the last 10 years. 240 ... for diagnostic scans on areas such as bone, lung perfusion, ...
... WellPoint,s PBM One of Only 13 Companies to Meet HRPA,s ... ... WellPoint NextRx, the nation,s,largest health plan-owned pharmacy benefit management (PBM) ... HR Policy Association (HRPA). Effective January 1,2008, the certification will ...
... Oct. 23rd, the fashion and,corporate worlds will join Hazelden ... Fifth Avenue, at "Fresh Start," Hazelden,s New York Awards,Dinner ... take place at,The Pierre Grand Ballroom. Bill Moyers will ... Collins. The event, which is sold out, is,expected to ...
... Group,Inc. (OTC Bulletin Board: SNVH) announced today that ... Practitioners in Women,s Health (NPWH),10th Annual Conference, "Women,s ... the leading association for nurse practitioners providing care ... - 13, in Philadelphia, PA.,The conference is expected ...
... anniversary, the American Association for Cancer Education (AACE) ... and minority cancer education. , AACEs 2007 Annual ... Hotel, 2101 Richard Arrington Jr. Boulevard North. The ... Underserved Populations. , The AACE meeting will draw ...
... MOINES, Iowa, Oct. 10 Protocol Driven Healthcare,Inc. ... online,health action plans to promote wellness and behavior ... Health action plans can be configured to ... duration of the program, action steps to,be included, ...
Cached Medicine News:Health News:Nuclear medicine now safer than ever 2Health News:Wellpoint NextRx Receives TIPPS Certification from the HR Policy Association 2Health News:Wellpoint NextRx Receives TIPPS Certification from the HR Policy Association 3Health News:Hazelden Honors Stephen I. Sadove, Chairman and CEO of Saks Fifth Avenue at its New York Awards Dinner to Benefit Youth and Families 2Health News:Hazelden Honors Stephen I. Sadove, Chairman and CEO of Saks Fifth Avenue at its New York Awards Dinner to Benefit Youth and Families 3Health News:Synova Healthcare to Participate in 'Women's Health Care in the New Millennium Conference,' as Retail Distribution for the Fem-V(R) Test Kit Expands 2Health News:Synova Healthcare to Participate in 'Women's Health Care in the New Millennium Conference,' as Retail Distribution for the Fem-V(R) Test Kit Expands 3Health News:Synova Healthcare to Participate in 'Women's Health Care in the New Millennium Conference,' as Retail Distribution for the Fem-V(R) Test Kit Expands 4Health News:US, European cancer educators gather in Alabama for meeting 2Health News:PDHI Launches ConXus Steps to Deliver Online Health Action Plans 2
... OptiEdge offers design innovations that ensure outstanding ... handling. The biostable acrylic material of the ... the patented OptiEdge is designed to both ... of contact with the posterior capsule; and ...
... posterior chamber lenses are optical implants for ... in the visual correction of aphakia in ... The optical portion consists of a high ... have biconvex optics and supporting haptics of ...
... Alcon introduces an intraocular lens ... Similar to the natural human lens, ... both UV and high-energy blue light. ... it won't spoil your patient's view. ...
... USIOL lenses are manufactured using ... processes. Perspex CQ UV PMMA ... multi-piece and single piece lenses. ... in both nonphaco and phaco ...
Medicine Products: